Authors


Adel Haque, MD

Latest:

Managing Atopic Dermatitis Postpartum and While Breastfeeding

A patient returns to your clinic seeking systemic therapy for her AD while postpartum and breastfeeding. Test your knowledge on injectables.


Shawn Kwatra, MD

Latest:

Practice Pearls for Managing Patients With Prurigo Nodularis

A panelist discusses how the advent of targeted systemic therapies such as dupilumab and nemolizumab has transformed the treatment landscape for prurigo nodularis, offering more effective options for breaking the itch-scratch cycle while maintaining favorable safety profiles compared with traditional systemic treatments.


Jeff Bendix

Latest:

Burnout, Frustration Levels Continue to Grow Among Physicians

Doctors cite more support staff, reduced patient panels among solutions.


Brandie Metz, MD

Latest:

Managing Your Pediatric Dermatology Practice and Life: Insights from Brandie Metz, MD, and Megha Tollefson, MD

Metz and Tollefson share insights on efficient practice management, work-life balance, and exciting developments in pediatric dermatology.


Terri L. Phillips, MD, FAAP

Latest:

The Changing Face of Aesthetics

Along with this new transparency regarding treatments, patients are empowered to embrace more comprehensive beauty ideals.



Stephen Zander, MBA

Latest:

How Can AI Improve Patient Care?

AI’s ability to quickly process and interpret large quantities of health data is a valuable tool for physicians.


Susan C. Olmstead, Editor

Latest:

Drug Combination May Benefit Patients with Transplanted Kidneys, Advanced Skin Cancers

In most kidney transplant recipients with advanced skin cancer, 2 checkpoint inhibitors are needed to boost the immune system, according to a new study.



Hope Mitchell, MD, FAAD

Latest:

Dermatology Times in France: What La Roche-Posay Products Dermatologists Recommend for Eczema, Acne

Dermatologists Jeanine Downie, DiAnne Davis, and Hope Mitchell reveal the La Roche-Posay products they recommend to patients with dry skin, eczema, and more, at the flagship store in France.


Daniel Siegel, MD

Latest:

Managing Dermatologic Surgery Challenges

Daniel Siegel, MD, shared strategies to manage surgery challenges, especially bleeding, to ensure a smooth experience for patients.


Gianna Melillo

Latest:

Study Underscores Need for More Effective Psoriasis Oral Therapies

Survey responses revealed the rates and times at which patients switched from oral to biologic therapies.


Nicholas Wrigley

Latest:

Data Support the Use of First-/Second-Line Immune Checkpoint Inhibitors in HNSCC

Findings from a retrospective cohort study found that immune checkpoint inhibitors induced promising responses in the first- and second-line treatment of head and neck squamous cell carcinoma.


Hadar Lev-Tov, MD

Latest:

Dermatologist Talks About the ABCs of Wounds and HS Support at Annual Meeting

Expert insights on the latest issues in wounds as well as HS resources are shared at the annual meeting.


Jeffrey Yager, MD

Latest:

Holistic Aesthetics Center to Host First Annual Symposium in Middletown, New York

Jeffrey Yager, MD, discusses the new SY Aesthetics campus that will integrate traditional and Chinese healing.


Sandra Fyfe

Latest:

Frontline Forum Part 4: Solutions in the Management and Treatment of Basal Cell Carcinoma

In part 4 of this Frontline Forum series, John M. Strasswimmer, MD, PhD; Andrew H. Weinstein, MD; Neal Bhatia, MD; Laura Ferris, MD; and Aaron S. Farberg, MD, discuss solutions for managing and treating patients with basal cell carcinoma.


Maggie L. Shaw

Latest:

Infertility Not Linked to Hidradenitis Suppurativa

In this study, the highest infertility rate was seen in the patients living with hidradenitis suppurativa; however, no direct causality was seen for this, with the authors noting diseases and symptoms comprised the only factors with a statistically significant relationship to infertility.


Michael Rubio, PA-C

Latest:

Don’t Under-Treat Hidradenitis Suppurativa: A Roadmap from Hesitant to Confident

Hidradenitis suppurativa requires clinical vigilance, empathy, and the courage to escalate therapy early.


Sponsored by ASLAN Pharmaceuticals

Latest:

The Crystal Ball: What This Means for the Future of Atopic Dermatitis Treatments

Peter Lio, MD, reflects on current unmet needs in atopic dermatitis and suggests directions for future research and development.


Anna López-Ferrer, MD, PhD

Latest:

Anna López-Ferrer, MD, PhD, and Volker Koscielny, MD, MBA, Share Highlights From Almirall’s 15th Skin Academy

López-Ferrer discussed how to achieve well-being for patients with psoriasis and Koscielny discussed the unique topics of the Skin Academy.


Heather Raglin, Editor

Latest:

The Many Considerations of Managing Generalized Pustular Psoriasis

Experts discuss the treatment landscape of generalized pustular psoriasis as well as review difficult cases of GPP.


Jerry Brewer, MD, MS, FACMS

Latest:

When to Call a Time Out on Mohs Surgery

Jerry Brewer, MD, MS, shared pearls on reasons to avoid or discontinue Mohs surgery and keeping calm with stressed, vulnerable patients.


Arash Mostaghimi, MD, MPA, MPH

Latest:

Deuruxolitinib Shows Efficacy in Hair Regrowth, Patient Satisfaction, and Psychosocial Wellbeing in Severe Alopecia Areata

Arash Mostaghimi, MD, MPH, MPA, provides insights into what clinicians need to know about deuruxolitinib for severe AA.


Jazmin Newton

Latest:

A Close Look at Necrobiosis Lipoidica

How to diagnose and treat this rare skin disorder.


Jennifer Fu, MD

Latest:

Award-Winning Research on Hair Loss Consensus Highlighted at Annual Meeting

The poster, which shares results form consensus research on using LODM for hair loss, was awarded 4th place at the 2024 AAD Annual Meeting.




Pete Haytaian

Latest:

3 Approaches to Creating a Connected Care Future

By integrating capabilities and services, we can create health experiences that are much more than the sum of their parts.


Natasha Mesinkovska, MD, PhD

Latest:

Diving Into Deuruxolitinib Data With Natasha Mesinkovska, MD, PhD

The investigator in the clinical development program for deuruxolitinib shared data, patient populations to consider, and more in a recent interview.


Kaiane Habeshian, MD

Latest:

Severe Hemorrhage from Infantile Hemangioma

A 5-month-old girl with a large scalp infantile hemangioma (IH), present since 6 weeks of age, is evaluated in the emergency department for lethargy and pallor.

© 2025 MJH Life Sciences

All rights reserved.